Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.1700 (-3.41%) ($101.1200 - $103.5600) on Fri. Jan. 3, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.38% (three month average) | RSI | 37 | Latest Price | $101.1700(-3.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND declines -1.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.19% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) UNG(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.19% (StdDev 2.38%) | Hourly BBV | 0 () | Intraday Trend | -1.9% | | | |
|
Resistance Level | $106.04 | 5 Day Moving Average | $104.21(-2.92%) | 10 Day Moving Average | $105.6(-4.2%) | 20 Day Moving Average | $106.04(-4.59%) | To recent high | -10.9% | To recent low | 1.1% | Market Cap | $1.626b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |